A Great Consumer Experience & Increased Revenue: The Avita Behavioral Health Crisis Center Case Study is starting in

Psychotropic Medication Linked To Increased Risk Of Dementia Following COVID-19

Older adults taking psychotropic medications had a higher risk of developing dementia following hospitalization for coronavirus disease 2019 (COVID-19). About 12.7% of older adults hospitalized for COVID-19 developed dementia in the year after the hospitalization. About 24% of those who took psychotropic medications developed dementia during the year after hospitalization, compared to 9% among those who did not take psychotropics. Those taking psychotropic medications were 1.7 times more likely to develop dementia

Each additional year of age was associated with a 5% increase of dementia following COVID-19. Across different drug classes, antipsychotics and mood stabilizers . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.